Vitamin D is the most-supplemented nutrient in America and one of the least-measured. Roughly a third of adults take it — most of them without ever having seen their own number, at doses chosen by shelf position. That’s backwards. The blood test is cheap, the dose-response varies wildly between people, and both directions of being wrong carry real costs. This is a marker where the order of operations is the advice: measure, then supplement, then measure again.
What the test actually measures
The test that matters is 25-hydroxyvitamin D — written 25(OH)D — the storage form your liver makes from sun exposure, food, and supplements. It has a half-life of two to three weeks, so it reflects your average vitamin D supply over the past couple of months, which is exactly what you want to know.
Here’s the trap worth ten seconds of your attention: labs also sell a test called 1,25-dihydroxyvitamin D — the short-lived active hormone your kidneys make on demand. It sounds more impressive and it answers the wrong question: your body defends the active form so hard that it can read normal or even high while your stores are running empty. Unless a physician is working up a specific kidney or calcium problem, 25(OH)D is the test. Read the analyte name before you order — the advice that applies to everything in this industry.
One more mechanical trap: units. U.S. labs report ng/mL; much of the world (and much of the internet) uses nmol/L, which runs 2.5× higher. A “50” is either comfortably replete or borderline depending on which unit it’s wearing.
Why your physical might skip it — and the honest version of that story
Vitamin D testing boomed in the 2010s, then guideline bodies pushed back — and the pushback deserves to be stated straight, because it’s the strongest argument you’ll meet. The Endocrine Society’s own 2024 guideline update recommends against routine 25(OH)D screening in generally healthy adults under 75, on the grounds that trials haven’t proven that testing-and-treating to a target level prevents disease in that population. Many insurers followed; a screening vitamin D test is now one of the most commonly denied lab claims.
So why measure at all? Because the guideline answers a population question — should everyone be screened? — and most people reading this page are asking an individual one: I’m tired, I’m indoors all day, I’m already taking 2,000 IU — is it doing anything? For that question, the case for measuring is practical, not ideological: the same daily dose can move one person 5 ng/mL and another 20 (body weight, baseline, sun, genetics all bend the curve), deficiency is common and silent, and unmonitored high-dose supplementation is precisely how the rare vitamin D toxicity cases happen. If you’re going to supplement — and a third of the country already does — the number is what separates a corrected deficiency from an expensive guess.
Normal, optimal, and the honest bands
There is no single agreed “optimal” — this marker has a genuine expert disagreement, and any chart that hides it is selling something. The two anchor positions:
| 25(OH)D (ng/mL) | The honest read |
|---|---|
| < 12 | Deficient by every body’s definition — associated with bone disease; worth fixing with a clinician involved |
| 12–20 | Below the National Academy of Medicine’s adequacy line (20); the zone ~40% of U.S. adults test in or under |
| 20–30 | Adequate per the National Academy; “insufficient” per the Endocrine Society’s earlier guidance — the contested band |
| 30–50 | Sufficient by both frameworks; where most clinicians who treat to a range aim |
| 50–100 | Above any demonstrated benefit; observational data hint the extra does nothing — supplement-driven levels here deserve a dose rethink |
| > 100 | Approaching toxicity territory (hypercalcemia risk) — essentially always a supplementation error; involve a clinician |
The disagreement, plainly: the National Academy of Medicine set 20 ng/mL as adequate for bone health for nearly everyone; the Endocrine Society’s 2011 guidance argued for 30 as the sufficiency floor; and the same society’s 2024 revision conceded that no outcome-specific target has been proven in healthy adults. A reasonable synthesis — the one you’ll hear from most physicians who look at these numbers daily — is that under 20 is worth correcting, 30–50 is a sensible resting place, and chasing 60+ has no evidence behind it.
Assay caveat: 25(OH)D methods have historically varied lab-to-lab enough to blur the 20-vs-30 line. Standardization has improved, but it’s one more reason to retest on the same lab when you’re tracking a trend.
No symptoms is the usual presentation
Real vitamin D deficiency mostly feels like nothing. Severe, prolonged deficiency shows up as bone pain, muscle weakness, and fracture risk — but the 15 ng/mL that four in ten adults are walking around with produces no reliable sensation at all. The popular fatigue link is honestly weaker than the internet says: low vitamin D and tiredness travel together in studies, but so do the things that cause both (indoor life, illness, winter). If fatigue is the complaint, vitamin D belongs on a differential, not a pedestal — drawn alongside ferritin and TSH, the two markers that far more often hold the actual answer.
What moves it
- Sun — UVB on skin is the native source, and it’s seasonal, latitude-dependent, and blocked by glass, sunscreen-as-directed, and melanin doing its job (darker-skinned adults run substantially lower on average at the same latitude).
- Body weight — vitamin D is fat-soluble and distributes into adipose tissue; higher-weight bodies typically test lower and need meaningfully more to move the number.
- Supplements — D3 raises 25(OH)D somewhat more reliably than D2. Response is roughly linear at moderate doses — on the order of 6–10 ng/mL per 1,000 IU/day for many adults — but the between-person spread is the whole point of retesting.
- Food — fatty fish, fortified milk, egg yolks; realistically a supporting actor. Malabsorption conditions (celiac, IBD, bariatric surgery) can flatten everything above.
The loop that closes the story: measure → adjust → retest in about three months. 25(OH)D takes two to three months to reach its new steady state after a dose change, so retesting sooner measures the transition, not the destination. This is the cadence almost nobody’s blog post finishes — a level without a follow-up draw is a snapshot of a moving target. (It’s also, stated plainly, what a testing membership is structurally built to do: the retest is the product.)
Vitamin D and the rest of the picture
- Ferritin — the other great silent nutrient deficit; in an unexplained-fatigue workup the two are drawn together and read against each other.
- TSH — completes the fatigue differential; “low D” has ended many workups that were actually thyroid stories.
- Magnesium (RBC) — a cofactor in the enzymes that activate vitamin D; a stubbornly low D that won’t respond to supplementation is sometimes a magnesium story, which is why the pair is read together.
- Calcium and kidney markers — the safety rails a physician reads next to a very high 25(OH)D before anyone keeps mega-dosing.
Browse the full biomarker library to see everything the panel covers.
How to get your vitamin D tested
Three realistic routes:
- Ask at your physical. Any lab runs 25(OH)D. Since the 2024 guideline shift, screening coverage is patchy — expect a possible cash bill even through your doctor, and make sure the order says 25-hydroxy, not 1,25-dihydroxy.
- Order it a la carte. Direct-to-consumer routes run roughly $30–81 all-in — every route priced in what a vitamin D test costs, including the $75–499 wrong test to avoid. Fine for a single data point — but the value of this marker lives in the retest loop, and a la carte pricing charges you list price every lap, with nobody adjusting the plan between draws.
- Measure it inside a full panel a physician actually reads. Terve Health is a whole-body panel — drawn at any of 2,000+ Quest locations, ordered by a licensed clinician, returned as a written plain-language review with your ferritin, thyroid, and metabolic markers read next to it, and retested on a schedule instead of a whim. You don’t choose a panel — a physician orders the right one for you. And if a result needs real follow-up, the medical practice behind your panel can actually see you.
Frequently asked questions
What is the optimal vitamin D level? Honestly contested. The National Academy of Medicine calls 20 ng/mL adequate for bone health; the Endocrine Society historically argued for 30+, and its 2024 update concedes no proven outcome target exists for healthy adults. Most physicians who treat to a range aim for 30–50 ng/mL and see nothing worth chasing above that. Under 20 is the zone with broad agreement that correction makes sense.
How much vitamin D should I take if my level is low? That’s genuinely a dose-for-your-body question — response varies several-fold between people with body weight, baseline level, and absorption. As orientation: the general adult RDA is 600–800 IU, the National Academy’s routine upper limit is 4,000 IU/day, and many adults move their level roughly 6–10 ng/mL per 1,000 IU/day of D3. The reliable method isn’t a bigger guess — it’s a measured baseline, a moderate dose, and a retest at three months, with a clinician involved for prescription-strength repletion.
How often should I retest vitamin D? About three months after any dose change — that’s how long 25(OH)D takes to reach its new steady state — then seasonally-aware maintenance checks (a summer number flatters you; a February draw tells the truth). Retesting sooner than ~8 weeks mostly measures the ramp.
My result says 50 — is that good? Check the unit first. 50 ng/mL (U.S. labs) is replete — top of the sensible range. 50 nmol/L (most other countries, many apps) converts to 20 ng/mL — the adequacy floor. This single conversion explains a remarkable share of vitamin D confusion online.
Can vitamin D be too high? Yes — essentially always from supplements, never from sun. Sustained levels above ~100 ng/mL risk hypercalcemia (nausea, kidney strain, worse), usually after months of very high doses taken unmonitored. It’s rare, it’s avoidable, and it’s the clearest argument this page makes: the people most enthusiastic about vitamin D are exactly the people who should be measuring it.
Sources
- Institute of Medicine (now NASEM). Dietary Reference Intakes for Calcium and Vitamin D. 2011. (20 ng/mL adequacy; RDA; 4,000 IU UL.)
- Demay MB, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024. (Against routine screening/targets in healthy adults <75.)
- Holick MF, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011. (30 ng/mL sufficiency position; repletion practice.)
- Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011. (~41.6% under 20 ng/mL, NHANES.)
- Heaney RP, et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003. (Dose-response slope; steady-state timing.)
- Tripkovic L, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status. Am J Clin Nutr. 2012. (D3 vs D2.)
- Sempos CT, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the Vitamin D Standardization Program. Br J Clin Pharmacol. 2018. (Assay variability/standardization.)
Terve Health measures and helps you understand your biomarkers; it does not diagnose, treat, or prevent disease. Laboratory testing performed by Quest Diagnostics®; testing is ordered and results are reviewed by licensed clinicians at an independent medical practice. Always discuss results and supplementation with a licensed clinician.